Squarepoint’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-29,030
| Closed | -$84K | – | 2679 |
|
2022
Q2 | $84K | Buy |
+29,030
| New | +$84K | ﹤0.01% | 1899 |
|
2022
Q1 | – | Sell |
-41,925
| Closed | -$195K | – | 3028 |
|
2021
Q4 | $195K | Buy |
41,925
+25,678
| +158% | +$119K | ﹤0.01% | 2107 |
|
2021
Q3 | $138K | Sell |
16,247
-120,655
| -88% | -$1.02M | ﹤0.01% | 1941 |
|
2021
Q2 | $2.25M | Buy |
136,902
+50,976
| +59% | +$837K | 0.01% | 753 |
|
2021
Q1 | $1.9M | Buy |
85,926
+65,772
| +326% | +$1.45M | 0.01% | 757 |
|
2020
Q4 | $623K | Buy |
+20,154
| New | +$623K | ﹤0.01% | 1344 |
|
2020
Q1 | – | Sell |
-13,937
| Closed | -$199K | – | 2625 |
|
2019
Q4 | $199K | Buy |
+13,937
| New | +$199K | ﹤0.01% | 2138 |
|